Physician profile
Peter A Tucich
NPI 1942338710
$2,621.10
in general payments reported to CMS, 2019-2025
20 companies · $964 in 2025
The $964 reported for 2025 was more than what 95% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2021: $326 · 2022: $265 · 2023: $101 · 2024: $829 · 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,893.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $587.67 | 2019-2025 | Apligraf, Puraply Wound Matrix, Affinity |
| Smith+Nephew, INC. | $575.85 | 2019-2025 | Oasis, Grafix Pl, Collagenase Santyl |
| Kerecis Limited | $470.72 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $206.75 | 2022-2025 | Nuzyra |
| Urgo Medical North America, LLC | $181.94 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Solventum Corporation | $118.85 | 2025 | Activ.A.C., Promogran Prisma, V.A.C. Veraflo |
| Convatec INC. | $75.88 | 2024-2025 | |
| Next Science LLC | $67.90 | 2022-2023 | Xperience, Surgx, Blastx |
| Kci USA, INC. | $66.70 | 2019 | |
| Advanced Oxygen Therapy INC. | $52.96 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Integra Lifesciences Corporation | $39.28 | 2024 | Tcc-Ez |
| Progenacare Global, LLC | $29.83 | 2024 | |
| Becton, Dickinson and Company | $27.40 | 2024 | Venclose Maven Catheter |
| Reapplix INC. | $25.75 | 2025 | 3c Patch Kit - Box |
| Abbvie INC. | $18.98 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $16.71 | 2025 | Theragenesis Wound Matrix |
| Astrazeneca Pharmaceuticals LP | $16.56 | 2023 | Andexxa |
| Reprise Biomedical, INC. | $14.86 | 2024 | Miro3d |
| Hartmann USA, INC. | $13.77 | 2025 | Zetuvit Plus 10x10 P10 |
| Cashflow Solutions, LLC | $12.74 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Tucich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.